Brainstorm Cell Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.05.18	BrainStorm Cell Therapeutics to Participate in Movement Disorder Panel at the Neurotech Investing and Partnering Conference (PR Newswire)
11.04.18	BrainStorm Cell Therapeutics to Present at ARM's 6th Annual Cell & Gene Therapy Investor Day, April 17 in New York (PR Newswire)
10.04.18	Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program Receives 2018 William J. Gies Award (PR Newswire)
28.03.18	BrainStorm Cell Therapeutics' Phase 3 Trial of NurOwn® in ALS Now Open to Canadian Patients (PR Newswire)
21.03.18	BrainStorm Appoints Two Leading Thought Leaders in the Fields of Neuroscience and Regenerative Medicine to its Scientific Advisory Board (PR Newswire)
15.03.18	BrainStorm Cell Therapeutics to Present at the BIO Asia International Conference and the Wall Street Investor Forum (PR Newswire)
12.03.18	BrainStorm Forms Scientific Advisory Board, Names Jerold Chun To Chair (RTTNews)
12.03.18	BrainStorm Announces Formation of Scientific Advisory Board and Appoints Neuroscientist Jerold Chun, M.D., Ph.D., to Chair (PR Newswire)
08.03.18	BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2017 (PR Newswire)
07.03.18	Van Morrison Joins Forces with Jazz Organ Virtuoso Joey DeFrancesco on You're Driving Me Crazy, a New Studio Album from Legacy Recordings Available Friday, April 27 (PR Newswire)
05.03.18	BrainStorm to Host an Annual Financial Results Call and Provide a Corporate Update on Thursday, March 8 (PR Newswire)
07.02.18	BrainStorm's NurOwn® Phase 2 ALS Clinical Trial and Biomarker Abstracts Accepted for Platform Presentations at the 70th Annual American Academy of Neurology Meeting in Los Angeles, California (PR Newswire)
06.02.18	BrainStorm Cell Therapeutics to Present at the BIO CEO & Investor Conference (PR Newswire)
05.02.18	BrainStorm Cell Therapeutics Appoints Senior Kite Executive, Anthony Polverino, Ph.D., to Board of Directors (PR Newswire)
16.01.18	BrainStorm to Present at Precision Medicine World Conference 2018 Silicon Valley on January 22 (PR Newswire)
03.01.18	BrainStorm Granted GMP Certification for a Marketing-Level Manufacturing of NurOwn® (PR Newswire)
29.12.17	Brainstorm Issues 2017 Letter to Shareholders (PR Newswire)
20.12.17	BrainStorm Cell Therapeutics to Present at the 10th Annual Biotech Showcase (PR Newswire)
07.12.17	Neptune Dash Nodes Corp. and Crossroad Ventures Inc. Announce Upsize of Previously Announced Private Placement Financing (PR Newswire)
07.12.17	Excedrin® Helps Cleveland Fans Deal With Headache From 0-16 "Perfect Season" (PR Newswire)
29.11.17	BrainStorm's Abstracts on Phase 2 NurOwn® Biomarkers Accepted for Presentation at the International Symposium on ALS/MND in Boston (PR Newswire)
09.11.17	New Peer Reviewed Publication Shows That BrainStorm's NurOwn® Has a Unique miRNA Signature (PR Newswire)
02.11.17	BrainStorm Strengthens Executive Team: Appoints Eyal Rubin as Chief Financial Officer (PR Newswire)
30.10.17	Olayan America And Chelsfield Unveil Plans For $300 Million Renovation Of 550 Madison Avenue And Announce Selection Of Snøhetta As Lead Architect (PR Newswire)
25.10.17	HJ Russell & Company Launches S.P.A.C.E. Venues Division (PR Newswire)
24.10.17	FDA Approves New Use For Soliris, HSTM In Good Health, BYSI Springs A Surprise (RTTNews)
23.10.17	BrainStorm Expands Its Patent Portfolio to Include a New US Patent For Its NurOwn® Technology for Parkinson's Disease And ALS (PR Newswire)
17.10.17	BrainStorm Announces Third Quarter 2017 Financial Results (PR Newswire)
16.10.17	BrainStorm Enrolls First Patients in Phase 3 Trial of NurOwn® in ALS (PR Newswire)
03.10.17	Brainstorm to Announce Third Quarter Financial Results And Provide Corporate Updates on Tuesday, October 17 (PR Newswire)
02.10.17	Höegh LNG Partners LP to Host Investor and Analyst Event on October 10, 2017 (PR Newswire)
27.09.17	BrainStorm Cell Therapeutics to Present at the 2017 Disruptive Growth Company Showcase NYC Presented by SeeThruEquity and RHK Capital (PR Newswire)
25.09.17	Le Conseil consultatif sur l'économie et l'innovation présente son rapport (PR Newswire)
15.08.17	Greenberg Traurig Co-President Hilarie Bass Assumes Role as President of the American Bar Association (PR Newswire)
15.08.17	BrainStorm Cell Therapeutics Q2 Net Loss Widens - Quick Facts (RTTNews)
10.08.17	Brainstorm to Host Second-Quarter 2017 Earnings Teleconference and Provide Important Corporate Updates, on Wednesday, August 16 (PR Newswire)
07.08.17	BrainStorm Supports Commitment to ALS Patient Community with Appointment of a Vice President of Patient Advocacy and Government Affairs (PR Newswire)
25.07.17	BrainStorm Announces Agreement with University of California Irvine Medical Center to Participate in Phase 3 Trial of NurOwn® in ALS (PR Newswire)
21.07.17	Brainstorm Awarded $16 Million Non-Dilutive Grant from CIRM in Support of Phase 3 Clinical Trial of NurOwn® in ALS (PR Newswire)
18.07.17	BrainStorm Announces Agreements with Mass. General Hospital and California Pacific Medical Center to Participate in Phase 3 Trial of NurOwn® in ALS (PR Newswire)
14.06.17	Nielsen Launches First-Ever Audio Data Management Platform with Westwood One as a Charter Client (PR Newswire)
14.06.17	BrainStorm to Provide Corporate Update at the BIO International Convention (PR Newswire)
13.06.17	BrainStorm Awarded $2.1 Million Non-Dilutive Grant for 2017 by the Israel Innovation Authority (PR Newswire)
22.05.17	BrainStorm to Present at Cell & Gene Exchange Conference in Washington DC (PR Newswire)
16.05.17	BrainStorm Initiated Technology Transfer to City of Hope for U.S. Production of NurOwn® for Phase 3 ALS Study (PR Newswire)
15.05.17	BrainStorm Announces First Quarter 2017 Financial Results and Provides Corporate Update (PR Newswire)
01.05.17	BrainStorm to Present at Two Scientific Conferences in May (PR Newswire)
20.04.17	Brainstorm Cell Therapeutics to Present at ARM's 5th Annual Cell & Gene Therapy Investor Day, April 27 in Boston (PR Newswire)
18.04.17	Gainers & Losers Of Apr.17: CBLI, INFI, PBYI, OMED, INCY... (RTTNews)
07.04.17	Gainers & Losers Of Apr.6: HTGM, AKTX, FGEN, ARLZ, ADAP... (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	302.80	1.30 %	K V
Alcon	76.88	0.65 %	K V
Sika	218.00	0.37 %	K V
Kuehne+Nagel Int	202.60	-0.20 %	K V
Logitech Intl	78.28	-0.33 %	K V
ABB	49.25	-1.44 %	K V
Holcim	87.68	-1.55 %	K V
Zurich Insur Gr	531.20	-1.63 %	K V
Roche Hldg G	267.20	-1.69 %	K V
UBS Group	29.78	-1.94 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Brainstorm Cell Therapeutics Inc

Aktien Top/Flop

Meistgelesene Nachrichten